ImmunoCellular Therapeutics Ltd(NYSEMKT:IMUC) shares added 2.12% to $1.01. ImmunoCellular Therapeutics, Ltd. is a clinical-stage biotechnology company. The Company is engaged in developing immune-based therapies for the...
Novavax, Inc.(NASDAQ:NVAX) shares climbed 0.39% to $5.18. Novavax, Inc. (Novavax) is a clinical stage biopharmaceutical company. The Company focuses on developing recombinant vaccines. The Company’s technology...